Finerenone and Kidney Outcomes in Patients with CKD and T2D: Results from FIDELITY

被引:0
|
作者
Bakris, George L. [1 ]
Ruilope, Luis M. [2 ,3 ,4 ]
Anker, Stefan D. [5 ,6 ]
Filippatos, Gerasimos [7 ]
Pitt, Bertram [8 ]
Rossing, Peter [9 ,10 ]
Fried, Linda F. [11 ]
Roy-Chaudhury, Prabir [12 ]
Sarafidis, Pantelis [18 ]
Ahlers, Christiane [16 ]
Joseph, Amer [13 ]
Brinker, Meike D. [13 ]
Lawatscheck, Robert [17 ]
Agarwal, Rajiv [14 ,15 ]
机构
[1] Univ Chicago, Dept Med, Med Infect Dis & Global Hlth, 5841 S Maryland Ave, Chicago, IL 60637 USA
[2] Inst Invest Ciencias Salud, Cardiorenal Translat Lab, Madrid, Spain
[3] Inst Invest Ciencias Salud, Hypertens Unit, Madrid, Spain
[4] CIBER CV Hosp Univ 12 Octubre, Ctr Invest Biomed, Madrid, Spain
[5] Charite Univ Med Berlin, Campus Virchow Klinikum, Dept Cardiol CVK, Berlin, Germany
[6] Charite Univ Med Berlin, Berlin Inst Hlth Ctr Regenerat Therapies, Berlin, Germany
[7] Ethniko Kai Kapodistriako Panepistemio Athenon Ia, Dept Cardiol, Athens, Greece
[8] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA
[9] Steno Diabet Ctr Copenhagen, Diabet, Gentofte, Denmark
[10] Univ Copenhagen, Kobenhavns Univ, Sundhedsvidenskabelige Fak, Copenhagen, Denmark
[11] Univ Pittsburgh, Sch Med, Dept Med, Div Renal Electrolyte, Pittsburgh, PA 15213 USA
[12] Univ N Carolina, Sch Med, Neurosci Ctr, Div Nephrol & Hypertens,Dept Med, Chapel Hill, NC USA
[13] Bayer AG, Cardiol & Nephrol Clin Dev, Wuppertal, Germany
[14] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA
[15] Indiana Univ Sch Med, Indiana Univ, Indianapolis, IN 46202 USA
[16] Bayer AG, Stat & Data Insights, Wuppertal, Germany
[17] Pharmaceut Bayer AG, Med Affairs & Pharmacovigilance, Berlin, Germany
[18] Aristoteleio Panepistemio Thessalonikes, Sch Med, Thessaloniki, Greece
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PO2531
引用
收藏
页码:B6 / B6
页数:1
相关论文
共 50 条
  • [1] Outcomes with Finerenone in People with CKD and T2D by Baseline Insulin Resistance-A FIDELITY Subgroup Analysis
    Ebert, Thomas
    Anker, Stefan
    Ruilope, Luis M.
    Fioretto, Paola
    Fonseca, Vivian
    Umpierrez, Guillermo
    Birkenfeld, Andreas L.
    Lawatscheck, Robert
    Scott, Charlie
    Rohwedder, Katja
    Rossing, Peter
    [J]. DIABETES, 2023, 72
  • [2] EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS IN PATIENTS WITH CKD AND T2D
    Ruilope, Luis
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Sarafidis, Pantelis
    Schmieder, Roland E.
    Joseph, Amer
    Mentenich, Nicole
    Nowack, Christina
    Bakris, George
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [3] CHARACTERISTICS OF FINERENONE INITIATORS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)
    Teng, Chia-Chen
    Singh, Rakesh
    Kong, Sheldon
    Djaraher, Rachel
    Williamson, Todd
    Farej, Ryan
    Willey, Vincent
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S75 - S75
  • [4] Efficacy and Safety of Finerenone in Patients with CKD and T2D by Baseline Insulin Treatment
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Macisaac, Richard
    Wainstein, Julio
    Joseph, Amer
    Roessig, Lothar
    Scott, Charlie
    Bakris, George
    [J]. DIABETES, 2021, 70
  • [5] Finerenone and Kidney Outcomes in Patients with CKD and Type 2 Diabetes: Results from FIGARO-DKD
    Bakris, George L.
    Ruilope, Luis M.
    Rossing, Peter
    Anker, Stefan D.
    Pitt, Bertram
    Filippatos, Gerasimos
    Mentenich, Nicole
    Lage, Andrea Z.
    Scheerer, Markus
    Joseph, Amer
    Agarwal, Rajiv
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 45 - 45
  • [6] Impact of Finerenone on Cardiac Biomarkers in Patients With T2D and Chronic Kidney Disease
    Berger, Mario
    Scalise, Andrea
    Kramer, Frank M.
    Paraschin, Karen
    Goea, Laura
    Kolkhof, Peter
    Rohwedder, Katja
    Skubala, Adam
    Voss, Sebastian
    Zannad, Faiez
    Rossing, Peter
    [J]. CIRCULATION, 2023, 148
  • [7] Finerenone in Patients across the Spectrum of CKD and T2D by GLP-1RA Use
    Rossing, Peter
    Anker, Stefan
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Fonseca, Vivian
    Umpierrez, Guillermo E.
    Caramori, Luiza
    Lambelet, Marc
    Viswanathan, Prabhakar
    Lawatscheck, Robert
    Joseph, Amer
    Bakris, George
    [J]. DIABETES, 2022, 71
  • [8] Efficacy and Safety of Finerenone in Patients with CKD and T2D by GLP-1RA Treatment
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Amod, Aslam
    Marre, Michel
    Joseph, Amer
    Lage, Andrea Z.
    Scott, Charlie
    Bakris, George
    [J]. DIABETES, 2021, 70
  • [9] Finerenone in Patients with CKD and T2D by SGLT-2i Treatment: An Analysis of the FIDELIODKD Study
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Chan, Juliana
    Kooy, Adriaan
    McCafferty, Kieran
    Schernthaner, Guntram
    Wanne, Christoph
    [J]. AMERICAN HEART JOURNAL, 2021, 242 : 160 - 161
  • [10] Efficacy and Safety of Finerenone in Patients with CKD and T2D by GLP-1RA Treatment
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Amod, Aslam
    Marre, Michel
    Joseph, Amer
    Lage, Andrea
    Scott, Charlie
    Bakris, George L.
    [J]. AMERICAN HEART JOURNAL, 2021, 242 : 160 - 160